Sfoglia per Rivista VASCULAR HEALTH AND RISK MANAGEMENT
Mostrati risultati da 1 a 9 di 9
Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia : patient selection and perspectives
2017 A.L. Catapano, A. Pirillo, G.D. Norata
Are pleiotropic effects of statins real?
2007 A. Corsini, N. Ferri, M. Cortellaro
Awareness, treatment, and control of major cardiovascular risk factors in a small-scale Italian community : results of a screening campaign
2013 S. Omboni, G. Carabelli, E. Ghirardi, S. Carugo
Combination therapy in cholesterol reduction : focus on ezetimibe and statins
2008 L. Grigore, G.D. Norata, A.L. Catapano
Diagnosis with ECG-gated MDCT of floating thrombus in aortic arch in a patient with type-A dissection
2008 D. Lumia, G. Carrafiello, D. Laganà, A. Musazzi, A. Giorgianni, A. Sala, C. Fugazzola
Epigenetic therapies for heart failure : current insights and future potential
2021 C. Napoli, P. Bontempo, V. Palmieri, E. Coscioni, C. Maiello, F. Donatelli, G. Benincasa
Metabolic syndrome, inflammation and atherosclerosis
2006 R. Paoletti, C. Bolego, A. Poli, A. Cignarella
Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL on the endothelium
2005 G.D. Norata, A.L. Catapano
The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation
2007 P. Gelosa, M. Cimino, A. Pignieri, E. Tremoli, U. Guerrini, L. Sironi
Mostrati risultati da 1 a 9 di 9
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile